Claritev (CTEV) EBIT Margin (2019 - 2026)
Claritev's quarterly EBIT Margin came in at 2.71% in Q1 2026, down 150.0% year-on-year from 5.43% in Q1 2025, and up 187.77% quarter-over-quarter from 3.09% in Q4 2025.
Claritev has reported EBIT Margin for 8 years, with the latest figure at 2.71% in Q1 2026.
- For the quarter ending Q1 2026, EBIT Margin fell 150.0% year-over-year to 2.71%; the trailing twelve-month figure through Mar 2026 stood at 2.62% (up 9899.0% YoY), and the FY2025 full-year result was 2.98%, up 15233.0% from the prior year.
- EBIT Margin for Q1 2026 stood at 2.71%, up from 3.09% in the prior quarter.
- The five-year high for EBIT Margin was 39.13% in Q1 2022, with the low at 254.48% in Q4 2022.
- Average EBIT Margin over 5 years is 40.08%, with a median of 4.21% recorded in 2025.
- Year-over-year, EBIT Margin plunged 29123 bps in 2022 and soared 27120 bps in 2023.
- Tracing CTEV's EBIT Margin over 5 years: stood at 254.48% in 2022, then soared by 107 bps to 16.72% in 2023, then plunged by 207 bps to 17.82% in 2024, then surged by 83 bps to 3.09% in 2025, then surged by 188 bps to 2.71% in 2026.
- The last three EBIT Margin figures came in at 2.71% (Q1 2026), 3.09% (Q4 2025), and 4.09% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 29.41% |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 3.36% |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 29.03% |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 17.59% |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 17.08% |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 25.64% |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | -11.30% |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 1.23% |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 5.44% |
| 10 | Claritev | 456.62 Mn | 428.62 Mn | 175.60 Mn | 2.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.71% |
| Dec 31, 2025 | -3.09% |
| Sep 30, 2025 | 4.09% |
| Jun 30, 2025 | 6.86% |
| Mar 31, 2025 | 4.21% |
| Dec 31, 2024 | -17.82% |
| Sep 30, 2024 | -146.73% |
| Jun 30, 2024 | -224.40% |
| Mar 31, 2024 | -207.43% |
| Dec 31, 2023 | 16.72% |
| Sep 30, 2023 | 16.28% |
| Jun 30, 2023 | 14.58% |
| Mar 31, 2023 | 19.84% |
| Dec 31, 2022 | -254.48% |
| Sep 30, 2022 | 14.53% |
| Jun 30, 2022 | 33.70% |
| Mar 31, 2022 | 39.13% |
| Dec 31, 2021 | 36.75% |
| Sep 30, 2021 | 36.24% |
| Jun 30, 2021 | 32.50% |
| Mar 31, 2021 | 32.28% |
| Dec 31, 2020 | -15.75% |
| Sep 30, 2020 | -89.26% |
| Jun 30, 2020 | 9.80% |
| Mar 31, 2020 | 34.77% |
| Dec 31, 2019 | 41.67% |